Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SMSLIFE Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong price momentum
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Negative
Low and declining ROE
Low but stable operating margin
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.331468.
Snapshot
See detailed analysis
SMSLIFE Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SMSLIFE Bulk, Block & Insider Trades
SMSLIFE Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Haleos Labs Limited, formerly, SMS Lifesciences India Limited, is an India-based company that is engaged in the business of manufacturing of active pharma ingredients (API) and their intermediates. The Companys API products include Ranitidine Hydrochloride (Form-2) USP / Ph. Eur / IP, Famotidine USP... Read More
Key personnel
Mr. N. Rajendra Prasad
Chief Financial Officer
Mr. Trupti Ranjan Mohanty
Compliance Officer, Company Secretary
Shri. Veeravenkata Satyanarayana Murthy TallurlD
Managing Director, Executive Director
Mrs. Sudeepthl GoplneedlD
Whole-time Director
Mr. Talluri Venkata PraveenD
Executive Director
Mr. P. Sarath KumarD
Non-Executive Independent Director
Dr. Mannam MalakondaiahD
Non-Executive Independent Director
Mrs. Sundaramma PatibandlaD
Additional Non-Executive Women Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Haleos Labs Ltd.?
The current share price of Haleos Labs Ltd. is ₹ 1,280.25 as of 09 Jan 2026.
What is the PE ratio of Haleos Labs Ltd.?
The Price-to-Earnings (PE) ratio of Haleos Labs Ltd. is 20.35 as of the latest financial data.
What is the ROE and ROCE of Haleos Labs Ltd.?
Haleos Labs Ltd. has a Return on Equity (ROE) of 9.65% and a Return on Capital Employed (ROCE) of 10.27% as per the latest financial reports.
What is the market cap of Haleos Labs Ltd.?
The market capitalization of Haleos Labs Ltd. stands at ₹ 387.02 Cr.
What is the dividend yield of Haleos Labs Ltd.?
The dividend yield of Haleos Labs Ltd. is 0.12% based on the current market price.
What is the RSI of Haleos Labs Ltd.?
The Relative Strength Index (RSI) of Haleos Labs Ltd. is 45.69.
What is the FII and DII holding in Haleos Labs Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Haleos Labs Ltd. shares.
What sector does Haleos Labs Ltd. belong to?
Haleos Labs Ltd. operates in the Healthcare sector.
What is the beta of Haleos Labs Ltd. stock?
The beta of Haleos Labs Ltd. stock is 0.87, indicating its volatility relative to the broader market.
